GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,000 | -66.7% | 108 | -58.6% | 0.00% | – |
Q1 2022 | $9,000 | -71.9% | 261 | -76.4% | 0.00% | – |
Q4 2021 | $32,000 | +28.0% | 1,106 | +15.0% | 0.00% | – |
Q3 2021 | $25,000 | -16.7% | 962 | +11.1% | 0.00% | – |
Q2 2021 | $30,000 | -16.7% | 866 | -2.0% | 0.00% | – |
Q1 2021 | $36,000 | +227.3% | 884 | +233.6% | 0.00% | – |
Q4 2020 | $11,000 | -21.4% | 265 | +6.0% | 0.00% | – |
Q3 2020 | $14,000 | -22.2% | 250 | 0.0% | 0.00% | – |
Q2 2020 | $18,000 | -53.8% | 250 | -68.9% | 0.00% | -100.0% |
Q3 2019 | $39,000 | -7.1% | 805 | +0.8% | 0.00% | -50.0% |
Q2 2019 | $42,000 | – | 799 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 355,509 | $17,171,000 | 9.58% |
Perceptive Advisors | 4,989,066 | $240,971,000 | 6.75% |
GREAT POINT PARTNERS LLC | 736,631 | $35,579,000,000 | 5.28% |
Casdin Capital, LLC | 600,000 | $28,980,000 | 5.10% |
Avoro Capital Advisors LLC | 1,765,548 | $85,276,000 | 4.07% |
Iguana Healthcare Management, LLC | 115,000 | $5,555,000 | 3.65% |
Camber Capital Management LP | 1,200,000 | $57,960,000 | 2.85% |
NEXTHERA CAPITAL LP | 315,147 | $15,222,000 | 2.51% |
RTW INVESTMENTS, LP | 456,921 | $22,069,000 | 2.10% |
EMORY UNIVERSITY | 41,610 | $2,010,000 | 1.44% |